Legal Representation
Attorney
John Patrick Sullivan
USPTO Deadlines
Application History
38 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Sep 9, 2021 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Sep 9, 2021 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
| Feb 25, 2021 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Feb 25, 2021 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Feb 25, 2021 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Feb 6, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Feb 5, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Feb 5, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Feb 5, 2021 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Feb 5, 2021 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Feb 5, 2021 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Feb 5, 2021 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Feb 5, 2021 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Aug 13, 2020 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Aug 13, 2020 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Aug 13, 2020 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Aug 13, 2020 | WOAR | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED | Loading... |
| Aug 13, 2020 | WOAG | I | WITHDRAWAL OF ATTORNEY GRANTED | Loading... |
| Aug 6, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Aug 6, 2020 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Aug 6, 2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jul 22, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jul 22, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jul 20, 2020 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Jul 8, 2020 | PROA | I | TEAS PETITION TO REVIVE RECEIVED | Loading... |
| Jul 8, 2020 | PETG | O | PETITION TO REVIVE-GRANTED | Loading... |
| Jul 8, 2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jul 8, 2020 | NREV | E | NOTICE OF REVIVAL - E-MAILED | Loading... |
| Mar 16, 2020 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Mar 16, 2020 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
| Sep 1, 2019 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Sep 1, 2019 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Sep 1, 2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Aug 23, 2019 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 18, 2019 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 18, 2019 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jan 16, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Dec 27, 2018 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for treating chemical imbalances; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for treatment of opioid addiction with pain management; Pharmaceutical preparations for cancer tumor cell remediation; Pharmaceutical preparations, namely, antidepressants; Anti-epileptic pharmaceutical preparations; Pharmaceutical preparations for cancer tumor cell remediation; Pharmaceutical preparations in the form of topical analgesics, tinctures, namely, medicinal herb extracts, and herbal anti-inflammatory salves for treating chemical imbalances, inflammation, epilepsy, depression, cancer, and opioid addiction with pain management; all of the foregoing containing or solely derived from CBD derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; anti-epileptic pharmaceutical preparations containing no CBD
First Use Anywhere:
Oct 6, 2018
First Use in Commerce:
Dec 20, 2018
Class 044
Dispensing of pharmaceuticals containing or solely derived from hemp with a delta-9 tetrahydrocannabinol THC concentration of not more than 0.3 percent on a dry weight basis; Dispensing of pharmaceuticals containing no CBD
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Pseudo Mark
PHARMACEUTICAL RX
Classification
International Classes
005
044